Individuals with EGF mutations were shown to have associated isolated recessive renal hypomagnesemia [29] and cancer patients treated with the EGFR inhibitor cetuximab have reduced serum Mg2+ levels that normalize upon therapy withdrawal [25,26]. The gene discussed is EGFR; the disease is cancer.